July 9, 2005

Consumer Reports comes out with their recommendations on calcium channel blockers
Note that CCBs are not first-line medications for hypertension. Also note that Pfizer’s Norvasc, the world’s best-selling antihypertensive, is nowhere to be found in the recommendations.



Related posts:

  1. Pfizer gives up on cardiac drugs
  2. What are the recommended vitamins that patients should take?
  3. Dilemma and high school football
  4. More Russert analysis
  5. Should Singulair be sold over the counter?
  6. Selling drug samples
  7. Psychiatric drug cocktails for kids


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: Previous Post

Next post: Next Post

Site Meter